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ABSTRACT

Exosomes are extracellular vesicles involved in intercellular communication. Bovine milk
exosomes stability and their biological effects on macrophages have not been
extensively investigated. Hence, the objectives of this study were to characterize bovine
milk exosomes and investigate their effects on RAW 264.7 macrophages under
normoxia and hypoxia. Bovine milk exosomes were isolated using differential
centrifugation and identified by the presence of exosomal markers (ALIX, TSG101, and
CD81) and particle size. The effect of in vitro digestion and pH on stability of milk
exosomes was investigated. The biological activity of milk exosomes in RAW 264.7
under normoxia was determined by measuring proliferation, expression of proliferation
markers p53, p21, cyclin D1, CDK2 and β-catenin, cell cycle, and the protective effect of
exosomes on cisplatin-induced cytotoxicity. The effect of exosomes on RAW 264.7
under hypoxia was assessed by measuring proliferation, ROS production, cytokines,
cell cycle, and the expression of hypoxia marker HIF-1α and proliferation markers p53
and p21. Exosomes were positive for exosomal markers and their size was 106.8 nm ±
3.4. Exosomal marker TSG101 was detected after digestion and exposure to different
pH values. The treatment of exosomes significantly increased proliferation in cells under
normoxia and had a protective effect against cisplatin-induced apoptosis. Proliferation
markers were significantly affected by exosome treatment under normoxia. Cell cycle
analysis in normoxia showed that exosome treatment reduced the percentage of preapoptotic cells while arresting the cells in G2/M phase. Hypoxic conditions reduced the
viability of cells by 27% while exosome treatment significantly increased the cell
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viability. Generation of ROS under hypoxia was significantly reduced in the cells treated
with exosomes. Hypoxia alone did not affect TNF-α, but exosome treatment significantly
increased TNF-α in a dose-dependent manner under hypoxia. Cell cycle analysis
showed that hypoxia alone arrested cells in the G0/G1 phase whereas exosome
treatment reduced the percentage of cells in this phase. The results demonstrated that
bovine milk exosomes isolated from commercially available milk are stable and affect
macrophage proliferation under normoxia and hypoxia indicating the potential role of
exosomes in the immune system. Further research is needed to understand milk
exosomes’ role in human health.
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW

1.1 Literature review
1.1.1 Exosomes
Exosomes are extracellular vesicles involved in cell-to-cell communication 1. Initially,
they were considered a waste product of the cells, but this common belief was
dismissed in 1983 when two papers reported that small vesicles around 50nm in size
were released from maturing blood reticulocytes 1,2. Since the discovery of exosomes
released from reticulocytes, their secretion has been well documented in many types of
cells and body fluids 3,4. It is important to mention that there are other types of
extracellular vesicle including ectosomes and apoptotic bodies 5. Even though there is
still some confusion about how to differentiate between different types of the
extracellular vesicles, it is a well-accepted notion that exosomes originate from
multivesicular bodies (MVB) while ectosomes originate from plasma membranes 6.
Apoptotic bodies, on the other hand, are made during the processes of programmedcell death called apoptosis. The size among different types of extracellular vesicles is
also another important characteristic that helps differentiate between them. Exosomes
are considered to be smallest among them with the size from 50-150nm while
ectosomes, also called microvesicles, size ranges from 50nm-1000nm 3. Apoptotic
bodies are considerably larger ranging from 800-5000nm 7. Thus, the particle size
distribution is an important parameter in exosomes isolation and identification.

1

1.1.2 Generation and release of exosomes
As mentioned previously, exosomes originate from multivesicular bodies. One of the
most commonly used definitions of generation of exosomes is that they are made by
inward budding of endosomes 8. It starts with the formation of an early endosome which
matures into a late endosome and formation of MVB. During this time, endosomal
membrane invaginates to make intraluminal vesicles (ILV) that will be released as
exosomes upon the endosome fusion with the cell surface 9. For the generation of ILVs
and consequently exosomes, there are two mechanisms known: endosomal sorting
complexes required for transport (ESCRT) dependent and ESCRT independent

10.

In

the ESCRT dependent mechanism, the ESCRT complex is recruited to the endosome
by transmembrane proteins that have been tagged with ubiquitin 5. It is important to
mention that tumor susceptibility gene 101 (TSG101) is also capable of recognizing
ubiquitin 5. Moreover, when TSG101 was knocked out, the secretion of exosomes was
significantly impaired suggesting its importance in exosomes generation

11.

In ESCRT

independent mechanism, ESCRT complex is not required, and the formation of
exosomes and sorting of exosomal cargoes is regulated by the members of tetraspanin
family CD9, CD63 CD81 and CD82 3. Once exosomes are formed within MVB, the fate
of MVB is to fuse with cell membrane and release exosomes out of cell or to fuse with
lysosome and be degraded; however, little is known about this process

12.

Once

exosomes are released from the cell, the exosome uptake by other cells depends on
the protein contained on the exosomes surface specifically tetraspanin family

2

13.

1.1.3 Function and significance of exosomes
Exosomes are small membranous vesicles with a major role in intercellular
communication. In general, exosomes contain various proteins, lipids, and nucleic
acids, and their content depends mostly on the type of cells they originate from

12.

Lately, the presence and importance of exosomal RNAs have been extensively
researched. Exosomes contain messenger RNA (mRNA) and micro RNA (miRNA) that
can be transferred to the recipient cell and deliver new genetic information

14.

By

transferring new genetic information, the protein expression of the recipient cell may be
altered. For instance, when human cells were incubated with mouse exosomes, distinct
mouse proteins were identified in human cells suggesting that exosomal mRNA can be
translated into proteins 15. Moreover, the transfer of exosomal RNA can differentially
affect the gene expression in the recipient cells 16. With possessing the ability to alter
the protein and gene expression, exosomes have been implicated in numerous
physiological and pathological processes 17. For example, in a physiological condition,
exosomes from dendritic cells may play an important role in activating immune system
while in a pathological condition, exosomes released from cancer cells may exchange
their oncogenic content with other cells 17. The function and therefore their significance
are closely related to the type of cells that exosomes originate from.

1.1.4 Exosomes isolation
One of the most commonly used methods for isolation of exosomes is differential
ultracentrifugation 4,18,19. Ultracentrifugation based method for exosomes isolation is
considered to be the gold standard 20. Differential centrifugation isolation method utilizes
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consecutive centrifugation steps with increasing speed and time. This method is based
on the principle that larger particles settle down first leaving the smaller particles in the
supernatant 21. Due to the size of exosomes and some size overlap with other
molecules and extracellular vesicles, ultracentrifugation yields exosomes that may be
contaminated 20. Ultracentrifugation can be accompanied by a density gradient which
separates exosomes based on their size, mass, and density in a preconstructed density
gradient medium 20. When exosomes are isolated based on density gradient using
sucrose gradient medium, they float in densities from 1.15 to 1.19 g/ml 22.
Another commonly used method of isolation of exosomes is size-based ultrafiltration 23.
The main principle of ultrafiltration and ultracentrifugation is the same, separation based
on the size. Using ultrafiltration, exosomes may be isolated based on molecular weight
or their size 20. However, the ultrafiltration method utilizes force which may contribute to
the loss of exosomes caused by rupturing their membranes

24.

Exosomes precipitation is another technique used in isolation of exosomes and involves
the use of polyethylene glycol (PEG) 25. The principle behind this method is that PEG
binds water molecules making other compounds to precipitate. Moreover, commercially
available kits such as ExoQuick (System Biosciences, United States) use PEG for
exosome isolation 26. However, it is important to mention that this method has its
disadvantages since other molecules such as protein can also precipitate making the
exosome isolates contaminated 27.
The presence of tetraspanins CD63, CD81, CD82, CD9 and ALIX among the other
exosomal markers is the principle behind affinity-based isolation techniques 25. Even
though affinity-based techniques can reduce isolation time and yield higher purity of
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exosomes, these techniques are expensive, inefficient and not recommended for
isolation from large volumes 26.

1.1.5 Detection and identification exosomes
Commonly used methods for detection of exosomes are dynamic light scattering, flow
cytometry and electron microscopy 28. However, dynamic light scattering favors larger
molecules when in heterogenous solution while electron microscopy can alter the shape
and size due to sample preparation steps 29. Both transmission electron microscopy and
scanning electron microscopy have been used to detect exosomes

30.

Regardless of the

cell type, almost all exosomes are made by inward budding of endosomes; therefore,
they contain proteins implicated in membrane transport and fusion (e.g., annexins,
flotillins), biosynthesis of multivesicular body (e.g. ALIX and TSG101) and processes
that require heat shock proteins integrins and tetraspanins (e.g. CD63, CD81)

31.

Not

surprisingly, the identification of exosomes has been heavily relying on the presence of
these proteins 18,32. Western blot and ELISA are commonly used techniques for
detection of exosomal proteins 28.

1.1.6 Bovine milk exosomes
Bovine milk is a nutrient rich-food that contains carbohydrates, lipids, proteins, minerals,
and vitamins. Bovine milk and its compounds have been extensively researched over
the years and their bioactivity have been well documented. Over the last 10 years,
research related to bovine milk gained more interest since the discovery of exosomes.
Earlier studies showed that microvesicles isolated from colostrum and mature milk were
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approximately 100 nm in size with a distinct phospholipid bilayer membrane

33.

In

addition, the study reported that isolated exosomal RNA from colostrum and mature
milk was translated into casein proteins suggesting that exosomal mRNA was intact

32.

Interestingly, bovine milk exosomes may have been isolated in 1973 when a study
found that bovine milk contains plasma membrane containing vesicles 34. However,
researchers at the time started becoming aware of the difference between these
vesicles and milk fat globule membranes (MFGM) 34,35 . Consequently, a study
published in 2012 investigated the difference between MFGM proteome and exosome
proteome 36. The study found that milk exosomes have different but also more diverse
proteome compared to MFGM proteome 35. After establishing the procedure for isolation
and characterization of exosomes, researchers investigated how Staphylococcus
aureus mastitis affects exosome proteome 37. Interestingly, the study found that the
infection changed protein expression of members of heat shock proteins,
protocadherin gamma family and to some extent casein proteins.
As the investigation on exosomes from the various cell was advancing and more
information was known, consequently, research on bovine milk exosomes was
advancing as well. In 2015, after transforming growth factor beta 1 (TGF-β1) was
discovered on the surface of cancer exosomes 38, a study found that bovine milk
exosomes are also enriched with TGF-β1 which can have immunoregulatory function
Moreover, a study published in 2017 found that bovine milk exosomes were enriched
with proteins implicated in immune responses, while mature milk exosomes were
enriched with proteins associated with transport and apoptosis suggesting that
composition of exosomes changes as the milk matures
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39.

19.

1.1.7 Stability of milk exosomes
As a potential food ingredient, the stability of milk exosomes across different food
matrices is imperative. However, the stability of bovine milk exosomes has not been
extensively investigated. In a study published in 2012, the researchers found that
bovine milk contains mRNA and miRNA that are very stable against acidic conditions
and RNAase treatment suggesting that these RNAs could resist manufacturing
processing 40. Since miRNA and mRNA may be enclosed into exosomes and thus
protected, another group of researchers was investigating whether exosomes would be
stable against a wide range of conditions. Interestingly, when isolated from
commercially available milk, exosomes were stable against low pH, boiling and multiple
freeze-thaw cycles 19. However, when the study that was published later investigated
whether the miRNA stability relies on the protection of exosomes, they concluded that
stability of miRNA did not depend exclusively on exosomes but also other extracellular
vesicles, proteins or lipids 41. MiRNA is small, non-coding RNA that is able to regulate
gene expression by binding to mRNA and preventing protein production

42.

The

importance of exosomal miRNAs and their implication in numerous pathological and
physiological processes 43 is what lead researchers to investigate bioactivity of bovine
milk exosomes.

1.1.8 Biological activity of bovine milk exosomes
Studies on the biological activities of bovine milk exosomes are limited but are gaining
interest among researchers. Initial studies on biological activities focused on
understanding if these bovine milk exosomes can be taken up by different cell types. In
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2013, a study found that macrovesicles isolated from bovine colostrum were taken by
RAW 264.7 cells 44. Moreover, the same study found that pretreatment with bovine milk
vesicles affected the production of IL-1, IL-6, and IL-10 in LPS-treated RAW 264.7 cells
suggesting that bovine milk exosomes have an immunomodulatory effect. Later in 2015,
a study found that bovine milk exosomes can be taken by human macrophage cell line
THP-1 45. Interestingly, the results demonstrated that only differentiated THP-1 cells
were able to uptake bovine milk exosomes. Immunoregulatory properties of bovine milk
exosomes isolated from commercially available milk were confirmed in another study 19.
The study found that bovine milk exosomes contain transforming growth factor beta
(TGF-β) on their surface and are able to differentiate naïve T-cells to T-helper 17 in
vitro. The researchers suggested that the immunomodulatory effect of bovine milk
exosomes on T-cell differentiation was associated with the presence of TGF-β.
The confirmation that bovine milk exosomes are taken by RAW 264.7 cells came from
the study published in 2015 46. Not only that bovine milk exosomes were taken up by
RAW 264.7 cells, but also the pretreatment with bovine milk exosomes before LPS
treatment, reduced the production of TNF-α and MCP-1 in adherent splenocytes
indicating that bovine milk exosomes could have some anti-inflammatory properties 46.
The bioactive properties of bovine milk exosomes were investigated in a recently
published paper where in vitro, human colonic goblet LS174T cells showed an increase
in mucus production when treated with bovine milk exosomes accompanied by
increased goblet cell-associated gene expression of TFF3

32.

In addition, in vivo,

administration of bovine milk exosomes significantly increased the number of goblet cell
in mice with necrotizing enterocolitis when compared to the untreated group and a
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decrease of myeloperoxidase expression was seen in mice treated with bovine milk
exosomes suggesting that bovine milk treatment prevented from the development of
NEC 32. Even with a limited number of publications, there is evidence that bovine milk
exosomes are biologically active, so a deeper understanding of their role in human
health is imperative.

1.1.9 Macrophages: cells of innate immunity
Immune cells can broadly be divided into two categories: cells of innate immunity and
cells of adaptive immunity. Macrophages, along with mast cells, dendritic cells, natural
killer cells, eosinophils, basophils, and neutrophils are cells of innate immunity.
Macrophages are primarily known to be professional phagocytes

47,

but their function

and role in the immune response are broader 48. Macrophages are motile cells
containing various receptors on their surface that help them recognize a wide range of
host and non-host ligands 47. Macrophages are not only able to engulf pathogenic
organisms but also to remove debris and dying (apoptotic) cells

49,50.

Different subpopulations of macrophages have been identified based on their function
and location 51. According to some sources, macrophages can be divided into two
groups: tissue-resident and monocyte-derived macrophages 52. It was believed that
tissue-resident macrophages originate from monocytes; however, there was enough
evidence that tissue macrophages originate from embryonic development rather than
circulating monocytes 53. The function of tissue-resident macrophages is to engulf
pathogens and to recruit other cells of immune system

51.

In a resting state,

macrophages that promote tissue repair are called M2 macrophages while
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macrophages that sense a microbe become M1 macrophages

54.

Polarization toward

M1 or M2 macrophages also can be achieved by the presence of different cytokines.
For instance, interferon gamma (IFN-γ) is a cytokine that promotes polarization of
macrophages toward M1 phenotype while interleukin 4 (IL-4) is needed to polarize
macrophages to M2 phenotype 55.
As mentioned previously, macrophages have numerous receptors which they use to
sense the environment around them

56.

Receptors such as Toll-like receptors (TLR),

Nod-like receptors (NLR) and scavengers are called pathogen receptors and are used
to sense microbes. TLRs are membrane receptors used to sense bacterial, viral or
fungal parts 56. NLRs are similar in their function to TLRs but they are located in the
cytoplasm and can recognize damage-associated molecular patterns (DAMPs) 57.
Scavenger receptors are membrane receptors and their function is to recognize
bacterial parts or altered-self 56.
One of the primary functions of macrophages is phagocytosis. When pathogenrecognition receptors such as dectin-1 on macrophages recognize pathogen-associated
molecular patterns, the process can initiate phagocytosis 58. Once the pathogen is
internalized, the killing of pathogens is achieved when the phagosome fuses with a
lysosome containing antimicrobial compounds 58. It is important to mention that one of
the best-studied phagocytosis processes is one that is facilitated by immunoglobulins G
(IgG) when Fcγ receptors on phagocytic cells recognize pathogens coated with IgG

59.

Interestingly, even though phagocytosis was discovered more than 100 years ago, the
process is not fully understood yet 59. Similarly to the pathogen recognition process,
apoptotic bodies need to be recognized in order to be phagocytosed by macrophage
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cells 58. Apoptotic bodies display molecules that are not normally present outside the
cells and those molecules are recognized by the phagocytes.
Another important function of macrophages is the secretion of numerous cytokines.
Cytokines are small proteins released by cells with a role in cell-to-cell communication
60.

The most important function of cytokines is to regulate inflammation, and they can be

divided into pro-inflammatory and anti-inflammatory cytokines 61. Pro-inflammatory
cytokines such as TNF-α, IL-1, and IL-6 are released after the cells sense the presence
of pathogens via their receptors 61. The first cytokine to be released after the indication
of immune responses is TNF-α 61. Although the function of TNF-α is complex, one of the
major roles of this cytokine is the resistance to infections 62. IL-6 function is also
complex including reduction of available iron seen in inflammation and differentiation of
naïve CD4+ T cells 63. To this date, 11 members of IL-1 cytokine family have been
identified and some of them have pro-inflammatory or anti-inflammatory properties 64.
IL-1β, as a member of IL-1 cytokine family, is a proinflammatory cytokine and its
secretion from the cell depends on the inflammasome formation

64.

The function of anti-inflammatory cytokine is to lessen inflammation and prevent tissue
damage from excess inflammatory response 65. One of the most potent antiinflammatory cytokines is IL-10 and its function is to inhibit the release of proinflammatory cytokines 65.

1.1.10 Cell cycle and cell proliferation
Cell cycle and therefore cell proliferation is a tightly regulated process. The cell goes
through phases gap 1 (G1), synthesis (S), gap 2 (G2) and finally mitosis (M) to produce
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two daughter cells. G1 phase prepare cells for DNA synthesis which happens in S
phase. Similarly, G2 phase prepares cells for mitosis which happens in the M phase of
the cell cycle 66. This process is heavily controlled to prevent the division of cells if DNA
is damaged. The cell has the ability to repair DNA damage; however, when DNA is too
damaged to be repaired, the cell would initiate programmed cell death known as
apoptosis 67. Development of cancer is followed by uncontrolled cell proliferation caused
by the cell inability to induce apoptosis when damage is too large to be repaired

68.

Factors involved in the cell cycle such as growth factors, oncogenes and antioncogenes play a role in the ability of cells to undergo apoptosis

69.

The central proteins that regulate the cell’s progression through different phases of the
cell cycle are cyclin-dependent kinases (CDKs) 69. To become activated, CDKs need to
be in the adequate phosphorylated state and in complex with cyclins

66.

Moreover, to

move to the next stage of the cell cycle, the cyclin from the previous stage needs to be
degraded 66. However, tumor suppressor protein p53 can negatively regulate the cell
cycle causing cell cycle arrest if DNA damage is present

70.

Activation of p53 leads to

activation of p21 which forms a complex with CDKs. The formation of a complex
between p21 and CDK2 or CDK4 will inactivate CDKs thus preventing progression from
G1 to S phase 71. One of the commonly used methods to analyze cell cycle is by flow
cytometry using a fluorescence dye that binds DNA. The principle behind cell cycle
analysis is that the amount of fluorescence is proportional to the amount of DNA
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72.

1.1.11 Hypoxia
Hypoxia is a phenomenon characterized by low oxygen concentrations that are not
enough to maintain cellular function

73.

In aerobic organisms, oxygen serves as the final

electron acceptor in the process of adenosine triphosphate (ATP) formation during
cellular respiration. The cells need a high constant ATP/ADP ratio to maintain normal
function hence oxygen depletion lead to reduced cell viability 74. Cells sense hypoxia by
different mechanisms and one of the ways is through mitochondria which is a primary
site of oxygen consumption 75. It is important to say that hypoxia can be acute and
chronic. While acute hypoxia can cause a disturbance in ion homeostasis, chronic
hypoxia can alter gene expression

73.

One of the first proteins that is activated in

hypoxia is hypoxia-inducible factor family (HIF) which comprises of three different
members HIF-1, HIF-2 and HIF-3 73. HIF-1 is the most ubiquitous and contains oxygen
sensitive alpha (α) unit that is destabilized in the presence of oxygen

76.

HIF-1α is

degraded in normoxia, thus hypoxia stabilizes HIF-1α which can dimerize with HIF-1β.
Once stabilized, HIF-1 can translocate into the nucleus and bind to targeted genes
altering their expression 73,77. Hypoxia can play an important role in cell proliferation,
differentiation, energy metabolism, acidosis, reactive oxygen species (ROS) formation
and apoptosis 73.
Swelling, heat, redness, and pain are four signs of inflammation. It is known that
reduced oxygen concentrations are seen in inflamed tissue mostly due to pressure
caused by swelling 78. Since hypoxia is associated with danger, the condition may result
in macrophages polarizing to a pro-inflammatory phenotype 79. It is documented that the
production of nitric oxide (NO) and TNF- α in macrophage cells is HIF-1α -dependent 80.
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Also, a previous publish study demonstrated that hypoxia resulted in significant ROS
generation and reduced cell viability in murine macrophage cell line RAW 264.7

81.

ROS

can damage DNA, proteins, and lipids but also have a beneficial effect in the cells of
innate immunity since it is involved in the direct killing of pathogens 82.

1.1.12 Macrophages and chemotherapeutic drugs
Cancer is the second leading cause of death in the United States 83. Chemotherapeutic
drugs are one of the available methods to treat cancer. The basic principle of
chemotherapeutic drugs is that it targets the cells that are dividing. By doing that,
chemotherapeutic drugs do not distinguish between healthy and cancer cell which can
cause apoptosis in healthy cells. For instance, when RAW 264.7 cells were treated with
doxorubicin, a chemotherapeutic drug, there was a significant decrease in cell viability.
However, when RAW 264.7 cells were treated with doxorubicin and bacterial
lipopolysaccharide (LPS), LPS prevented doxorubicin-induced apoptosis 84. Developing
new drugs that will protect the healthy cell from killing while targeting cancer cells is still
a challenge 85.

1.2 Hypothesis and objectives
Hypothesis of this study are:
1. Exosomes are stable against in vitro digestion and changes in pH.
2. Bovine milk exosomes will affect RAW 264.7 cells proliferation by affecting cell
cycle.
Objectives of this study are:
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1. To isolate and characterize exosomes from commercially available bovine milk.
2. To investigate the effect of bovine milk exosomes in RAW 264.7 cell under
hypoxia and normoxia.
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2.1 Abstract
Exosomes are extracellular vesicles involved in intercellular communication. The
objectives were to characterize bovine milk exosomes and determine its effect on the
proliferation of RAW 264.7 macrophages. Bovine milk exosomes were isolated using
differential centrifugation and identified by the presence of exosomal markers (ALIX,
TSG101, and CD81) and the particle size. The effect of in vitro simulated
gastrointestinal digestion and different pH on stability of milk exosomes was
investigated. The biological activity of milk exosomes in RAW 264.7 was conducted by
measuring proliferation, expression of proliferation markers p53, p21, cyclin D1, CDK2
and β-catenin and analysis of cell cycle. Moreover, the protective effect of exosomes on
cisplatin-induced cytotoxicity in macrophages was investigated. Exosomes were
positive on exosomal markers and their size was 106.8 nm ± 3.4. Exosomal marker
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TSG101 was detected after digestion and exposure to different pH values. Proliferation
markers were affected by exosome treatment. Cell cycle analysis showed that
exosomes treatment reduced the percentage of pre-apoptotic cells while arresting the
cells in G2/M phase. Exosomes had a protective effect against cisplatin-induced
apoptosis in macrophages. The results demonstrated that bovine milk exosomes
isolated from commercially available milk are stable and affected macrophage
proliferation indicating its potential role in the immune system. Further research is
needed to understand its role in human health.

2.2 Introduction
Bovine milk is a nutrient-rich food containing lipids, proteins, minerals, and vitamins that
are needed for the growth and development of the calf. It contains immunoglobulins,
hormones, growth factors, cytokines, enzymes and bioactive peptides 1. The
immunoregulatory effect of bovine milk peptides in humans has been well documented
2.

An animal study suggests that oral administration of bovine lactoferrin and

lactoperoxidase may attenuate pneumonia in mice infected with influenza virus 3. The
results from multiple clinical trials suggest that bovine lactoferrin may reduce the
incidence of sepsis in neonates 4. Furthermore, pretreatment with bovine milk may
prevent acid and alcohol-induced gastric ulcer development in mice 5. Clearly, the
consumption of milk has numerous potential benefits in human health.
Exosomes are extracellular vesicle (30-120nm) and their synthesis and secretion have
been documented in the most types of cell 6. Exosomal cargo heterogeneity depends on
the type of the cell and may contain nucleic acids, enzymes, lipids and proteins 7.
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Exosomes play an important role not only in cell-to-cell communication via transfer of
the exosomal cargo from donor to recipient cell but also angiogenesis, cell survival,
inflammation and immune response 8,9.
Recently, food-sourced exosomes have been identified from different plants including
ginger, carrots, grapefruit, and grape and they can alter the gene expression in the
recipient cells 10. Moreover, isolation and identification of exosomes have been reported
in human and commercially available bovine milk

11,12.

Human milk exosomes are stable

against in vitro digestion and are taken by human intestinal cells in vitro 11. In another
study, oral administration of extracellular vesicles isolated from commercially available
milk lessened arthritis in mice 12.
Previous studies have revealed that bovine milk exosomes contain miRNA and
messenger RNA 13,14. In the previously mentioned study, a very small difference in
microRNA expression between exosomes isolated from raw and commercially available
milk may suggest that heat treatment (pasteurization) does not affect exosome
bioavailability 14. Micro-RNA has been implicated in numerous physiological and
pathological processes including cancer 15. The US Centers for Disease Control and
Prevention predicts that in the near future, cancer will be the leading cause of death in
the United States. Chemotherapy is one of the available treatments for cancer;
however, it does not distinguish between healthy and cancer cells. Protecting the
heathy cells from the cytotoxic effect of chemotherapeutic drugs is still a major problem
in cancer treatment 16.
Bioactivity of bovine milk exosomes and their potential use as a functional food
ingredient is still unknown. Therefore, the objective of this study was to isolate,
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characterize and investigate the effect of pH and in vitro simulated gastrointestinal (GI)
digestion on the stability of exosomes. Also, the biological activity of bovine milk
exosomes and its effect on murine macrophage cell line RAW 264.7 with and without
the chemotherapeutic drug cisplatin was investigated.

2.3 Materials and methods
2.3.1 Materials
Murine macrophage RAW 264.7 cell line was purchased from American Type Culture
Collection (Manassas, VA). Growth media DMEM 1X was purchased from Corning Inc.
(Corning, NY). Fetal bovine serum (FBS) was purchased from Life Technologies
(Carlsbad, CA). Primary antibodies (PDCD 61P (ALIX) 12422-1- AP, TSG 101 14497-1AP, CD81 18250-1-AP, CDK2 60312-1-Ig, β-catenin 51067-2-AP, p53 10442-1-AP, p21
60214-1-Ig, cyclin D1 60186-1-Ig, and GAPDH 60004-1-Ig) were purchased from
Proteintech (Rosemont, IL). Secondary antibodies (goat anti-mouse and goat antirabbit) were purchased from Thermo Fisher Scientific (Waltham, MA).

2.3.2 Isolation of exosomes
Exosomes were isolated from commercially available fat-free milk (Great Value brand)
by differential centrifugation under sterile conditions following previously described
protocol with some modifications 17. Briefly, milk was centrifuged at 13,000 x g at 4 °C
for 30 min in 250 mL centrifuge bottles using SS-34 rotor and SORVALL® RC-5B PLUS
centrifuge. The whey was collected, transferred into polycarbonate 26.3 mL Beckman
centrifuge tubes, and centrifuged at 100,000 x g at 4 °C for 60 min in Type 50.2 Ti rotor
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using Optima XL-80K Ultracentrifuge (Beckman Coulter, Inc.). The final supernatant
was collected, transferred to 26.3 mL centrifuge tubes and centrifuged at 135,000 x g at
4 °C for 90 min. The supernatant was discarded, and the pellet was washed with PBS
twice. The exosome pellet was collected and resuspended in PBS. Isolated exosomes
were sterile filtered through 0.22 µm filters. The protein concentration of exosomes was
adjusted to 6 mg/mL and stored at -80 °C until further use.

2.3.3 Characterization of milk exosomes
The protein concentration of exosomes was determined by Pierce

TM BCA

Protein Assay

Kit (Thermo Scientific, Rockford, IL U.S.A). Exosomes were diluted to 1 mg/mL
concentration for particle size and zeta potential analysis. The size and zeta potential
were measured by Zetasizer (Malvern Instruments Ltd., Malvern, Worcestershire, UK).
Protein profile of exosomes was assessed by SDS-PAGE and exosomal protein
markers tumor susceptibility gene 101 (TSG101), cluster of differentiation 81 (CD81),
and programmed cell death 6-interacting protein (PDCD 6IP-ALIX) were detected by
western blot analysis described below.

2.3.4 Effect of pH on exosomes stability
Exosomes were diluted to 1 mg/mL concentration using PBS. Then, 10 mL of diluted
exosomes was adjusted to different pH values (2, 3, 4, 5, 6, 8, 9, 10, 11, and 12) using
hydrochloric acid (HCl) and sodium hydroxide (NaOH) accordingly. pH-adjusted
samples were stirred at 550 rpm for 20 min at room temperature (RT). After stirring, the
samples were centrifuged at 10,000 x g for 10 min at 4 °C. The supernatant was
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collected, and the protein concentration of the supernatant was determined. The particle
size and zeta potential of pH-adjusted samples were measured. Protein profile and the
presence of exosomal markers TSG101, CD81 and ALIX was assessed by SDS-PAGE
and western blot analysis, respectively.

2.3.5 Pepsin-pancreatin digestion of exosomes
Pepsin- pancreatin digestion was performed following previously reported procedure

18.

Two milliliters of approximately 6 mg/mL exosomes were mixed with 8 mL PBS and the
pH of the sample was adjusted to 2.0 using HCl. Pepsin was added at a 1:10
enzyme:protein ratio. Pepsin digestion was carried out for 60 min in a shaking water
bath at 37 °C. To inactive pepsin, pH was adjusted to 7.5 using sodium hydroxide. A 5
mL aliquot was taken and centrifuged at 10,000 x g for 10 min to remove any large
particles. The supernatant was collected and used for further analysis. Pancreatin and
bile were added to the remaining pepsin samples at a 1:10 enzyme: protein ratio, and
the pancreatin digestion was carried out for 60 min in a shaking water bath at 37 °C.
Pancreatin was inactivated by heating the samples at 75 °C for 20 min. Pancreatin
samples were centrifuged at 10,000 x g for 10 min at 4 °C, and the supernatant was
collected. Pepsin and pancreatin samples were analyzed for protein content, particle
size, and zeta potential. Protein profile and the presence of TSG101, CD81, and ALIX
was assessed by SDS-PAGE and western blot, respectively.
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2.3.6 SDS-PAGE and western blot detection of TSG 101, CD 81 and ALIX
Isolated exosomes, pH-adjusted, and digested samples were mixed with an equal
volume of 2x Laemmli sample buffer (Bio-Rad Laboratories, Inc.) containing 5% βmercaptoethanol and heated in boiling water for 5 minutes. An equal amount of protein
(for pH-adjusted samples) and an equal volume (for digested samples) of samples were
loaded into Mini-Protean ® TGXTM gel (Bio-Rad Laboratories, Inc.) and run in Bio-Rad
Tris/Glycine/SDS buffer at 200 volts for 35 minutes. The gel was washed with deionized
(DI) water 3 times (5 min each), and 50 mL of Bio-SafeTM Coomassie G-250 stain was
added and gently shaken for 1 hour. The gel was rinsed with DI water for 30 min. For
western blot analysis, after SDS-PAGE, the gel was equilibrated in blotting buffer for 15
min. The proteins were transferred onto an AmershamTM HybondTM 0.45 µm
polyvinylidene difluoride membrane (PVDF) at 110 volts for 60 min at 4 °C. The PVDF
membrane was blocked with 5% non-fat dry milk in Tris-Buffered Saline -0.01% Tween
20 (TBST) for 1 h at room temperature. After blocking, the membrane was washed in
TBST three times each time for 5 min. The membrane was incubated with primary
antibodies against TSG101, CD81 and ALIX (Proteintech Group, Inc. IL, USA) at 1:1000
dilution overnight at 4 °C. After washing, secondary anti-rabbit antibodies at 1:5000
dilutions were incubated for 1.5 h at room temperature. The membrane was washed,
saturated with Bio-Rad ClarityTM Western ECL Substrate and imaged by a C-Digit blot
scanner (Li-Cor Biosciences, U.S.).
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2.3.7 Cell culture and cell proliferation assay
Murine macrophages RAW 264.7 were cultured in DMEM containing 10% fetal bovine
serum and 1% penicillin/streptomycin and at 37 ºC in 5% CO2 until confluency. Briefly, 2
X 105 cells/well were seeded into a 6-well plate in the total volume adjusted to 2 mL and
incubated overnight to attach at 37 ºC in 5% CO2. After overnight incubation, the cells
were treated with different exosomes concentration ranging from 30 to 250 µg/mL for 24
h. The cells were harvested according to the protocol described below. For proliferation
assay, 5 X 103 cells/well were seeded into a 96-well plate in the total volume 200 µL and
incubated overnight to attach at 37 °C in 5% CO2. Then, the cells were treated with
different exosomes concentration (15 to 250 µg/mL) with or without cisplatin (5 µM) for
24h. After the treatment, the growth media was replaced with 100 µL fresh plain growth
media containing 10% MTS reagent and incubated for 3 h under the same conditions as
described above. The absorbance was read at 490 nm and the percent of viable cells
was calculated with respect to untreated cells.

2.3.8 Whole cell lysate preparation
After the cells were treated, 6-well plates were placed on ice and the growth media was
removed. The cells were washed twice with ice-cold PBS to remove cell debris. After
washing, 100 µL radioimmunoprecipitation assay (RIPA) lysis buffer containing 1%
protease inhibitor complex was added to each well and incubated for 5 min. Cells were
harvested by scraping and transferred to 1.5 mL microfuge tubes and vortexed at 14,
000 x g for 10 minutes at 4 °C. The supernatant was collected, and protein
concentration was measured using Bradford reagent and BSA as the standard. The

35

supernatant was mixed with Laemmli buffer containing 5% β-mercaptoethanol in equal
volumes and boiled for 5 min. The samples were stored at -80 °C until use.

2.3.9 Western blot for proliferation proteins p21, p53, β-catenin, cyclin D1 and
CDK 2
Approximately, 10 µg of the protein of the cell lysate was loaded in 8-16% SurePAGE
(GenScript) gels. The gel electrophoresis was run in Tris-MOPS-SDS (GenScript)
running buffer at 140 volts for 50 min. Proteins were transferred into the Trans-Blot®
TurboTM PVDF membrane (Bio-Rad) using Trans-Blot®TurboTM Transfer System (BioRad). After the transfer, the membrane was blocked with 5% non-fat dry milk in TBST
for 1 h at room temperature. After blocking, the membrane was washed in TBST three
times each time for 5 min. The membrane was incubated with primary antibodies
against cyclin-dependent kinase inhibitor 1 (p21), cyclin-dependent kinase 2 (CDK 2)
and β-catenin at dilution 1:1000, tumor protein (p53) at dilution 1:3000, and cyclin D1
and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) at dilution 1:5000 overnight
at 4 °C. After incubation, the membrane was washed as described above and
secondary antibodies (anti-rabbit for p53 and β-catenin and anti-mouse for p21, cyclin
D, CDK 2 and GAPDH) at dilution 1:5000 were incubated for 1.5 h at room temperature.
Finally, the membrane was washed, saturated with Bio-Rad ClarityTM Western ECL
Substrate and imaged by a C-Digit blot scanner (Li-Cor Biosciences, U.S.).
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2.3.10 Cell-cycle analysis by flow cytometry
The cells were fixed and stained following the previously described protocol

19.

Briefly,

the cells were seeded in 6-well plates and treated with exosomes (60 and 250 µg/mL)
and with cisplatin and exosomes (60 µg/mL) following above described protocol. After
treatment, the plates were placed on ice, and the media was removed. The cells were
washed with ice-cold PBS twice. Two hundred µL of growth media was added to each
well and the cells were scraped. Additional 800 µL of growth media was added to each
well and cells were transferred to 1.5 mL microfuge tubes. The cells were centrifuged at
1000 x g for 5 min at 4 °C. After centrifugation, the supernatant was removed, and the
cells were resuspended in 60 μL PBS. Then, 70% ethanol was added to the cell
suspension drop by drop with constant vortexing. The cells were left overnight at 4 °C
for fixation. After fixation, cells were centrifuged at 300 x g at room temperature, the
supernatant was removed and 1 mL staining mixture containing propidium iodide and
RNase was added. The cells were vortexed and incubated for 1 h at 37 °C protected
from light. Cell cycle analysis was performed using MACSQuant flow cytometer and
data analyzed with MACSQuantify software (Miltenyi Biotec, Somerville MA).

2.3.11 Statistical analysis
All experiments were performed in at least three independent replicates. All results are
expressed as mean±SD or mean±SEM. Analysis of variance (ANOVA) with Tukey’s test
was done to determine a significant difference (p<0.05) between different treatment
groups using Minitab statistical software (Minitab Inc., Pennsylvania, USA).
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2.4 Results and discussion
2.4.1 Characterization and identification of bovine milk exosomes from
commercially available milk
Bovine milk exosomes were isolated from commercially available milk using differential
centrifugation technique. Milk exosomes were characterized by particles size
distribution and surface zeta potential by dynamic light scattering. Fig 2.1A ( all figures
are located in the appendix) shows the average particle size of bovine exosomes was
106.8nm ± 3.427 with a polydispersity index (PDI) of 0.227 ± 0.019 consistent with
previously reported values 17. The average zeta potential was -9.88mV ±- 0.706 (Fig
2.1B). Zeta potential is one of the important parameters that influence nanoparticle
stability 20. Zeta potential in this range suggests short time particle stability while zeta
potential in the range from -5 mV to +5 mV would indicate a fast aggregation

20.

For further characterization and identification, exosome lysates were prepared and
analyzed using western blot for the presence of exosomal markers. As shown in Fig
2.1C, milk exosomes were positive for ALIX, TSG101, and CD81. Despite the cell type,
almost all exosomes have endosomal origin; therefore, they contain proteins implicated
in membrane transport and fusion (e.g., annexins, flotillins), biosynthesis of
multivesicular body (e.g. ALIX and TSG101) and processes that require heat shock
proteins integrins and tetraspanins (e.g. CD63, CD 81) 6. Consequently, exosomes
identification has been relying heavily on the presence of exosomal proteins such as
Alix, TSG101, and proteins of tetraspanin family 17,21.
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2.4.2 Bovine milk exosomes are stable against pH changes
The effect of pH on milk exosomes has not been studied well. There is a limited number
of research that have been done on the exosome’s stability and quality as affected by
different pH. As a potential functional food ingredient, the stability of milk exosomes
over a range of pH is of crucial importance for food application. As seen in Fig 2.2A,
exosomes solubility is dependent on the pH of the solution. At pH 4, milk exosomes are
the least soluble. The isoelectric point of milk casein is 4.6 which may suggest that
some proteins may be present in the exosome’s solution and precipitate at pH close to
isoelectric point of casein. Proteins are least soluble around and at isoelectric point, and
as pH changes away from the isoelectric point, protein solubility increases. Bovine milk
exosomes are most soluble at pH 7.4 which is close to milk pH. In a previously
published letter, the results showed that when exosomes were exposed to pH 4 and pH
10, exosomes concentration decreased

22.

Further, Fig 2.2B shows that particle size of

exosomes is also dependent on the pH of the solution. The particle size of exosomes is
smallest at pH 5 (91.96nm ± 4.267) but the most uniform particle size is at pH 4 with
PDI of 0.093±0.017. This would confirm that larger particles precipitate at pH 4 point
leaving in the solution smaller particles with similar size including exosomes. Largest
PDI (0.305 ± 0.01) is at pH 6 showing that different size populations are present at this
pH condition and it may suggest that at this point, the solution would not be stable. Zeta
potential is an important parameter that influences the stability of nanoparticles. In Fig
2.2C, it can be seen that surface zeta potential is also dependent on solution pH. As pH
decrease, zeta potential increase and vice versa. This can be explained that proteins at
lower pH are protonated making the surface more positively charged
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23.

Zeta potential

reaches zero value at pH between 3 and 4. At this value, exosomes are least soluble,
and the solution would not be stable. Exosomal protein TSG101 was detected in all
different pH exosome solutions (Fig 2.2D). At these protein concentrations, ALIX and
CD 81 were not detected (not shown). A reduction in TSG101 signal can be seen at pH
12. Clearly, extremely high pH values decrease exosomes quantity which is consistent
with reported results 22. However, even though soluble protein concentration at pH 12
remains almost not changed when compared to exosomes at pH 7.4, TSG101
concentration decrease. This suggests that proteins other than exosomal marker
TSG101 may be present in isolated exosomes and these proteins are highly soluble at
higher pH.

2.4.3 Bovine milk exosomes resist pepsin-pancreatin hydrolysis
The application of milk exosomes as a potential functional food ingredient depends on
the ability of exosomes to survive human digestion and to reach intestines and
circulation in an intact form. Exosome size slightly increased (123.2nm ± 3.394) after
subjecting exosomes to pepsin like-conditions with a wider particle size range (Fig
2.3A). Moreover, particle size decreased (113.5nm ± 0.167) when pepsin-digested
exosomes were subjected to pancreatin part of digestion, but still, the particle size was
larger than the size of non-digested exosomes (Fig 2.3A). This may be explained by
structural changes in exosomes exposed to simulated pepsin digestion. However, after
pepsin-pancreatin hydrolysis, the particle size range was narrower suggesting that
some large particles have been partially hydrolyzed at this point. The protein
concentration of pepsin and pancreatin like solution remained unaffected (data are not
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shown). The effect of in vitro digestion on milk exosomes stability has not been
extensively researched. Recently, the results of a study suggested that milk exosomes
isolation was not affected by subjecting milk to in vitro digestion prior to the isolation and
there was no difference in exosomes size, morphology and miRNA content when
compared to exosomes isolated from undigested milk

24.

Moreover, the same study

found that milk exosomes were able to pass human intestinal epithelium in vitro using
Caco-2 cell culture suggesting that milk exosomes may be able to reach the blood
circulation.
Pepsin-pancreatin hydrolysis did not affect zeta potential. However, this may be
explained by non-significant changes in solution pH. After digesting exosomes with
pepsin at pH 2, pepsin digestion was stopped with adjusting pH to neutral conditions
(~7.5). Pepsin-pancreatin digestion was performed at the same neutral pH condition
with no change in zeta potential suggesting that the pH of solution is one of the
important factors that influences zeta potential. Pepsin-pancreatin digestion did reduce
the signal of exosomal markers (Fig 2.3C). After the pepsin digestion, TSG101 and
CD81 were detected with CD81 signal being lower than that one of TSG 101.
Furthermore, after pepsin-pancreatin digestion, only TSG101 was detected. Clearly,
there was a reduction in TSG101 signal when compared to the non-digested and
pepsin-digested samples. The presence of TSG101 suggests that exosomes survive in
vitro digestion.
Following in vitro digestion and effect of pH, exosome proteins profile was investigated
by SDS-PAGE (Fig 2.3D). The most apparent bands and reduction of the same bands
in hydrolyzed and exosomes exposed to low pH are seen between 25 kDa and 37kDa
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which corresponds to the molecular weight of casein proteins

25.

Also, a slight reduction

at pH 2, pH 3 and pH 4can be seen at 75kDa band. In the previous study of human milk
exosomes, bands in this range were suggested to be related to protein lactoferrin which
is also abundant in bovine milk and has been found to have antibacterial,
immunomodulatory and anti-cancer activity 11,26. Even though there is a reduction in the
appearance of some bands, clearly some proteins are still present even after complete
pepsin-pancreatin digestion suggesting that exosomes are resistant to simulated
digestive conditions.

2.4.4 Bovine milk exosomes affect proliferation and have a protective effect on
cisplatin treated RAW 264.7 cells
Macrophages are cells of the immune system involved in the first line of defense during
infection 27. In Fig 2.4A, treatment with bovine milk exosomes increases proliferation of
RAW 264.7 cells in a dose-dependent manner. Treatment with 15, 30, and 60 μg/mL
bovine exosomes significantly increased proliferation when compared to untreated
macrophages. At 250 µg/mL, macrophage proliferation was significantly increased by
49.7% when compared to untreated cells. Interestingly, the proliferation of RAW 264.7
was not accompanied by activation of the cells since nitric oxide, and proinflammatory
cytokines (e.g. TNF-α, IL-6) were not produced (data not shown). The effect of different
compounds on inflammatory responses and activation of RAW 264.7 have been widely
researched. Mostly, these research papers focus on compounds that are capable of
activating RAW 264.7 while inducing nitric oxide and cytokine production (proinflammatory) or alleviating inflammatory responses (anti-inflammatory)28,29. Our results
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showed for the first time that food-derived compounds, such as bovine milk exosomes,
can influence macrophage proliferation.
Further, when cells were co-treated with exosomes and cisplatin (5 μM), treatment with
exosomes increases macrophage cell survival indicating a protective effect of bovine
milk exosomes against cisplatin-induced cytotoxicity as shown in Fig 2.4B. At a
concentration of 250 μg/mL exosomes, the cell survival of 95.3% was significantly
increased when compared to the survival of 81.2% when cells were treated with
cisplatin only. The proliferation of macrophages as well as the potential cytotoxic effect
of chemotherapeutic drugs such as cisplatin is not well studied. Cisplatin is a
chemotherapeutic drug that binds to DNA and prevents its repair causing cells to go to
apoptosis 30. However, cisplatin, as majority of other chemotherapeutic drugs, is not a
selective agent meaning it does not distinguish between healthy and cancer cells.
Protective effect of bovine milk exosomes may contribute to a better understanding of
how to protect normal cells from the cytotoxic effect of chemotherapeutic drugs.

2.4.5 Bovine milk exosomes affect proliferation markers (proteins) in RAW 264. 7
cells
Proliferation markers such as p21 and p53 play an important role not only in cell
proliferation and cell cycle but also in the immune response in macrophage cells

31,32.

Fig 2.5 shows a dose-dependent effect of bovine milk exosomes treatment on
proliferation markers in RAW 264.7 cells. In our study, exosomes treatment with 60 and
250 μg/mL significantly increased β-catenin expression by 42.5% and 40.8%,
respectively, when compared to untreated macrophages. β-catenin is a protein involved
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in multiple functions including development, tissue homeostasis, cell renewal, adhesion
and cell signaling 33. Recently, the role of β-catenin in infections and immune cells was
investigated. In a couple of studies, the role of β-catenin in the immune system cells
susceptibility to different bacterial and viral agents was investigated 34,35. In the abovementioned study, overexpression of β-catenin in Pseudomonas aeruginosa infected
RAW 264.7 cells promoted bacterial elimination with no effect on NO and ROS
production 34. In addition, investigators found that an increased level of β-catenin in
monocytes when compared to monocyte-derived macrophages suppressed HIV
replication suggesting that β-catenin plays an in important role in HIV replication 35.
Bovine milk exosomes increased p53 expression in RAW 264.7 in a dose-dependent
manner with 250 μg/mL exosome treatment significantly increasing p53 expression by
2-fold when compared to negative control. The p53 protein has a vital role in cell
proliferation by repairing DNA and inducing apoptosis when DNA damage is too serious
to be repaired 36. Also, a frequent p53 mutation in cancer cells makes this protein as a
potential target in normal cells that would prevent them from the killing effect of
chemotherapeutic drugs 16. Increased expression of p53 protects normal cells from the
cytotoxic effect of chemotherapeutic drugs 16 is consistent with our observation that
bovine milk exosomes protected macrophages against cisplatin-induced cytotoxicity.
Moreover, in one study, transient overexpression of p53 in RAW 264.7 significantly
reduced Listeria monocytogenes invasion when compared to control cells. In vivo
results from the same study confirmed that knocking out p53 expression accelerated
and increased lethality in mice 32.
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Bovine milk exosomes also significantly affected p21 expression (Fig 2.5). At a
concentration of 250 μg/mL, p21 expression was significantly increased by 66.8%. p21
is transcriptionally regulated by p53 and it has numerous functions in the cell cycle and
apoptosis. For instance, overexpression of p21 in several cell type can protect cells
from apoptosis 37. Also, in a previous study, the role of p21 in LPS-stimulated peritoneal
macrophage was investigated and the results showed that deletion of p21 was
accompanied by an increase in the production of pro-inflammatory cytokines TNF-α and
IL-1β 31. While CDK-2 expression levels in RAW 264. 7 cells were not significantly
affected by exosomes treatment (p=0.08), cyclin D1 expression was significantly
affected. It can be seen that bovine milk exosomes treatment reduced the expression of
cyclin D1 in a dose-dependent manner where treatment with 60 µg/mL and 250 µg/mL
reduced the expression by 36.2% and 51.8% respectively when compared to untreated
cells. Cyclin D1 is one of the regulators of the cell cycle progression from G1 to S phase
and its quick degradation is required for cells to move from G1 to S phase 38. Also, in a
previous study, the results showed that Bac1.2F5 macrophages treated with IFN-γ
showed an increased level of cyclin D1 resulting in blocking macrophage proliferation
A decrease in the expression of cyclin D1 upon treatment of exosomes may play an
important role in the proliferation of macrophages making cells progress to the next
phase in the cell cycle.
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2.4.6 Milk bovine exosomes affect the cell cycle of RAW 264.7 with and without
cisplatin
Fig 2.6 shows the effect of bovine milk exosomes on RAW 264.7 proliferation cell cycle
with or without cisplatin treatment. Exosomes treatment affected the proliferation of the
cells in a dose-dependent manner. In the absence of cisplatin (Fig 2.6A), the number of
apoptotic cells when macrophages were treated with exosomes was significantly
reduced by 37.9% and 53.35% when cell treated with 60µg/mL and 250 μg/mL
respectively although there was no significant difference between the two exosomes
concentrations. Also, the reduction of cells by 10.7% can be seen in the G0/G1 phase of
the cell cycle when cells are treated with 250 µg/mL exosomes. The exosomes
treatment arrest cells in S and G2/M phase. In the S phase, 250 µg/mL exosomes
treatment increased the number of cells by 16.0%, while in G2/M phase the cell number
increased by 47.9%. To our knowledge, there have been only very few research
conducted on RAW 264.7 cell cycle. One of the papers was investigating how
Salmonella infection affects the cell cycle in RAW 264.7

40.

In a study of the effect of

riboflavin deprivation in RAW 264.7, when cells were deprived of riboflavin, the results
showed a decrease in the S and G2/M phase 41. On the other hand, another study
reported that cypermethrin treatment increased the percentage of the cells in G1;
therefore, inducing death by arresting cells in this phase

42.

Our results indicate that an

increase in proliferation is accompanied by an increase in S and G2/M phase.
When RAW 264.7 cells were treated with exosomes and cisplatin (5 µM), exosomes
treatment (60 µg/mL) reduced the number of pre-apoptotic cells by 17.4% when
compared to the cells treated with cisplatin only (Fig 2.6B). Cisplatin treatment arrests
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the cells in pre-apoptotic phase. Moreover, exosomes treatment in the presence of
cisplatin reduced the number of cells in the G0/G1 phase by 35.9% when compared to
the cells treated with cisplatin only. Arrest in G2/M phase was seen in the cells treated
with exosomes and cisplatin with an increase in the number of cells by 28.5%.

2.5 Conclusion
Our study found that commercially available milk exosomes resist in vitro digestion and
pH change. Moreover, this is the first report on how bovine milk exosomes affected
proliferation of macrophages, an important component of our immune system. Bovine
milk exosomes also protected macrophages against cisplatin-induced cytotoxicity by
affecting the expression of proteins involved in cell cycle and proliferation. Further
research is needed to better understand the role of bovine milk exosomes and their
effect on human health.
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Figure 2.1. Characterization of milk exosomes by particle size distribution (A) and zeta
potential (B). Identification of milk exosomes by western blot analysis on exosomal
markers ALIX, TSG101, and CD81 (C).
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Figure 2.2. Stability of exosomes at different pH values presented as solubility of milk
exosome proteins over a range of pH values (A), particle size distribution with PDI (B),
surface zeta potential (C) and detection of exosomal protein TSG101 (D). Results are
presented as mean ± SD (A, B, and C).
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Figure 2.3. Effect of simulated pepsin-pancreatin digestion on size (A), and zeta
potential of milk exosomes (B), the presence of exosmal proteins ALIX, TSG101 and
CD81 (C), and the effect of pH and pepsin-pancreatin hydrolysis on the protein profile
using SDS-PAGE (D). Results are presented as mean ± SD (B).
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Figure 2.3 continued. Effect of simulated pepsin-pancreatin digestion on size (A), and
zeta potential of milk exosomes (B), the presence of exosmal proteins ALIX, TSG101
and CD81 (C), and the effect of pH and pepsin-pancreatin hydrolysis on the protein
profile using SDS-PAGE (D). Results are presented as mean ± SD (B).
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Figure 2.4. Effect of milk exosomes on RAW 264.7 proliferation without (A) and with
cisplatin (B). Results are presented as mean ± SD. Means that do not share a letter are
significantly different (p<0.05).
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Figure 2.6. Cell-cycle of RAW 264.7 cell treated with bovine milk exosomes without (A)
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share a letter are significantly different (p<0.05).
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CHAPTER 3: THE EFFECT OF BOVINE MILK EXOSOMES ON THE
PROLIFERATION OF RAW 264.7 CELLS UNDER HYPOXIA
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3.1 Abstract
Exosomes are extracellular vesicles implicated in cell-to-cell communication and their
secretion has been documented in almost all types of cells. The objective of this study
was to isolate exosomes from commercially available milk and investigate its effect in
RAW 264.7 cells under hypoxia. Exosomes were isolated from commercially available
skim milk using differential centrifugation and their presence was identified by particle
size and exosomal markers TSG101, CD81, and ALIX. The effect of bovine milk
exosomes on RAW 264.7 cells under hypoxia was investigated by assessing
proliferation, cytokine and ROS production, and cell cycle. Moreover, the hypoxia
marker HIF-1α and proliferation markers p53 and p21 were assessed by western blot.
The average size of exosomes was 152.2 nm ± 4.25 measured by dynamic light
scattering method. Exosomes treatment increased the cell viability under hypoxia when
compared to untreated cells. ROS production was significantly reduced with exosomes
treatment (p<0.05). The production of TNF-α was not affected by hypoxia alone but
increased in a dose-dependent manner in cells treated with exosomes under hypoxic
condition. Hypoxia arrested cells in the G0/G1 phase whereas exosome treatment
reduced the cell in this phase. However, there was no effect on the expression of HIF1α, p53, and p21. Our study found that bovine milk exosomes affect the proliferation of
RAW 264.7 cell under hypoxia and are able to reverse the adverse effects of hypoxia on
cell viability.
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3.2 Introduction
Hypoxia is a condition that is characterized by low oxygen concentrations caused by the
low blood supply to the body’s tissue. Not all forms of hypoxia are deleterious to body
tissue. In some cells and tissue, such as intestinal epithelial cells, low oxygen
concentrations are considered physiological, hence the term physiological hypoxia 1.
However, when an environment of low oxygen causes the impaired function of the cells
and tissues, hypoxia can become pathological. Often, the reduction of blood supply and
consequent low oxygen concentrations can be seen in the inflamed and injured tissue.
This is due to the inability of blood vesicles to grow and supply oxygen to the growing
affected tissue caused by infiltration of the cells 2. Consequently, hypoxia may cause
immune cell impairment and dysfunction.
Macrophages are the cells of the innate immune system and their primary function is
phagocytosis. They exist in our body in two different forms: tissue-resident and
monocyte-derived macrophages 3. When a pathogen gets sensed, one of the functions
of the tissue-resident macrophage is to start initiating inflammatory response 4. In an
environment of low oxygen tension, which is often seen in inflammation, macrophages
upregulate some genes in order to perform their function in hypoxic environment.
Hypoxia-inducible factor family is one of the genes that is upregulated in low oxygen
conditions and upregulation of HIF-1α is implicated in hypoxia-induced apoptosis 5,6.
Furthermore, when macrophage cells were infected with Escherichia coli and
Staphylococcus aureus and exposed to hypoxic conditions, the ability of macrophages
to eliminate these two pathogens was significantly reduced even though these
pathogens are readily killed by macrophages under normoxic conditions 7.
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Consequently, hypoxia and its effect on the cells of the immune system have been
extensively investigated and alternative ways such as the application of bioactive food
compounds in lessening the effects of hypoxia have been a novel approach.
Exosomes are extracellular vesicles with sizes ranging from 50-150nm 8. Their
synthesis and secretion have been well documented in almost all types of cells 9. Lately,
the presence and isolation of exosomes from different foods including milk and edible
plants and their effect on human health have been investigated

10,11.

It has been

documented that bovine milk exosomes contain miRNAs that are resistant to in vitro
digestion and are taken up by the human macrophage cell line THP-1 12,13. Moreover, in
a recently published study, bovine milk exosome treatment prevented the development
of necrotizing enterocolitis in vivo 14.
The effect of food derived exosomes on hypoxia-induced changes has not been
extensively investigated. Moreover, a recently published study found that bovine milk
exosomes increased the proliferation of intestinal epithelial cells in vitro under hypoxia
15.

Therefore, the objective of this study was to isolate bovine milk exosomes from

commercially available milk and investigate its effect on the proliferation of murine-like
macrophages RAW 264.7 under hypoxic conditions.

3.3 Materials and methods
3.3.1 Materials
Murine macrophage RAW 264.7 cell line was purchased from American Type Culture
Collection (Manassas, VA). Growth media DMEM 1X was purchased from Corning Inc.
(Corning, NY). Fetal bovine serum (FBS) was purchased from Life Technologies
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(Carlsbad, CA). Primary antibodies (p53 10442-1-AP, p21 60214-1-Ig, HIF-1α 20960-1AP, and GAPDH 60004-1-Ig) were purchased from Proteintech (Rosemont, IL).
Secondary antibodies (goat anti-mouse and goat anti-rabbit) were purchased from
Thermo Fisher Scientific (Waltham, MA).

3.3.2 Isolation and characterization of bovine milk exosomes and particle size
analysis
Exosomes were isolated from commercially available fat-free milk by differential
centrifugation under sterile conditions following previously described protocol with some
modifications16. Briefly, milk was centrifuged at 13,000 x g at 4 °C for 30 min in 250-mL
centrifuge bottles using SS-34 rotor and SORVALL® RC-5B PLUS centrifuge. The whey
was collected, transferred into polycarbonate 26.3-mL Beckman centrifuge tubes, and
centrifuged at 100,000 x g at 4 °C for 60 min in Type 50.2 Ti rotor using Optima XL-80K
Ultracentrifuge (Beckman Coulter, Inc.). The final supernatant was collected, transferred
to 26.3-mL centrifuge tubes and centrifuged at 135,000 x g at 4 °C for 90 min. The
supernatant was discarded, and the pellet was washed with PBS twice. The exosome
pellet was collected and resuspended in PBS. The protein concentration of exosomes
was determined by Pierce TM BCA Protein Assay Kit (Thermo Scientific, Rockford, IL
U.S.A). Exosomes were diluted to 1 mg/mL concentration for particle size and zeta
potential analysis. The size and zeta potential were measured by Zetasizer (Malvern
Instruments Ltd., Malvern, Worcestershire, UK). Exosomal marker TSG101, CD81, and
ALIX were determined by western blot. Isolated exosomes were sterile filtered through
0.22 µm filters and stored at -80 °C until further use.
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3.3.3 Cell culture and cell proliferation assay
Murine macrophages RAW 264.7 were cultured in DMEM containing 10% fetal bovine
serum and 1% penicillin/streptomycin and at 37 ºC in 5% CO2 until confluency. For
proliferation assay, 5 X 103 cells/well were seeded into a 96-well plate in the total
volume of 200 µL and incubated overnight to attach at 37 °C in 5% CO2. Then, the cells
were treated with different exosomes concentration (0, 100 and 200 µg/mL) and placed
in a hypoxia chamber for 24 h. The composition of the gas in the hypoxia chamber was
94% N2, 5% CO2 and 1% O2. Untreated cells were incubated under normoxia. After the
treatment, the growth media was replaced with 100 µL fresh plain growth media
containing 10% MTS (Promesa, Madison WI) reagent and incubated for 3 h under
normoxia. The absorbance was read at 490 nm and the percent of viable cells was
calculated with respect to untreated cells under normoxia.

3.3.4 Whole cell lysate preparation and supernatant collection
Briefly, 2 X 105 cells/well were seeded into a 6-well plate in the total volume adjusted to
2 mL and incubated overnight to attach at 37 ºC in 5% CO2. After overnight incubation,
the cells were treated with 0, 100 and 200 μg/mL exosomes and placed in a hypoxia
chamber containing 94% N2, 5% CO2 and 1% O2 for 24h. Untreated cells were
incubated under normoxia. After 24h of treatment, the 6-well plates were placed on ice
and the growth media was collected for cytokine analysis. The cells were washed twice
with ice-cold PBS to remove cell debris. After washing, 100 µL radioimmunoprecipitation
assay (RIPA) lysis buffer containing 1% protease inhibitor complex was added to each
well and incubated for 5 min. Cells were harvested by scraping and transferred to 1.5
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mL microfuge tubes and vortexed at 14, 000 x g for 10 min at 4 °C. The supernatant
was collected, and protein concentration was measured using Bradford reagent and
BSA as the standard. The supernatant was mixed with Laemmli buffer containing 5% βmercaptoethanol in equal volumes and boiled for 5 min. The samples were stored in -80
°C until use.

3.3.5 Production of ROS by flow cytometry
Briefly, RAW 264.7 cells were seeded, treated and incubated in the 6-well plates under
normoxia and hypoxia following the above-mentioned protocol. After treatment, the
plates were placed on ice and the media was removed. The cells were washed with icecold PBS twice. Two hundred µL of growth media was added to each well and the cells
were scraped. Additional 800 µL of growth media was added to each well and cells
were transferred to 1.5 mL microfuge tubes. The cells were centrifuged at 1,000 x g for
5 min at 4 °C. After centrifugation, the supernatant was removed, and the cells were
resuspended in 1 mL PBS. The cells were again centrifuged at 1,000 x g for 5 min at 4
°C and supernatant was removed. Finally, the cells were resuspended in 500 μL PBS
containing 10 μM 2’,7’-dichlorofluorescein diacetate and incubated at 37 °C for 30 min in
a CO2 incubator. The number of cells with green fluorescence was measured using the
FL 1 channel of a MACSQuant flow cytometer and data was analyzed with
MACSQuantify software (Miltenyi Biotec, Somerville MA).
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3.3.6 Enzyme-linked immunosorbent assay (ELISA) for measurement cytokine
production (IL-1β, IL-6, IL-10 and TNF-α)
Production of IL-1β, IL-6, IL-10 and TNF-α was measured using commercially available
ELISA kits (BioLegend, San Diego CA). The cytokine detection was performed using
the supernatant collected after the cell treatment with exosomes. Briefly, uncoated
plates were incubated with capture antibodies overnight at 4 °C. After incubation, the
plates were washed with washing buffer 4 times and blocked with assay diluent for 1 h
with shaking at room temperature. After blocking, the plates were washed, and
standards and samples were plated and incubated with shaking at room temperature for
2 h. The plates were washed after the sample incubation and detection antibodies were
added and incubated for 1 h with shaking after which the plates were washed and the
avidin-HRP solution was added and incubated for 30 min with shaking. Finally, after
washing, the substrate solution was added and incubated in the dark for 15 or 20 min.
The stop solution was added, and absorbance was read at 450 nm. The concentration
of cytokines was calculated based on the standard curve for each cytokine.

3.3.7 Western blot for hypoxia marker HIF-1α and proliferation proteins p21 and
p53
Approximately, the 10 µg of proteins of the cell lysate was loaded in 8-16% SurePAGE
(GenScript) gels. The gel electrophoresis was run in Tris-MOPS-SDS (GenScript)
running buffer at 140 volts for 50 min. Proteins were transferred into the Trans-Blot®
TurboTM PVDF membrane (Bio-Rad) using Trans-Blot®TurboTM Transfer System (BioRad). After the transfer, the membrane was blocked with 5% non-fat dry milk in TBST
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for 1 h at room temperature. After blocking, the membrane was washed in TBST three
times for 5 min each. The membrane was incubated with primary antibodies against
cyclin-dependent kinase inhibitor 1 (p21) at dilution 1:1000, tumor protein (p53) at
dilution 1:3000, hypoxia-inducible factor-1α (HIF-1α) at 1:1000 dilution and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (house-keeping protein; for
normalization of data) at dilution 1:5000 overnight at 4 °C. After incubation, the
membrane was washed as described above and secondary antibodies (anti-rabbit for
p53 and HIF-1α and anti-mouse for p21 and GAPDH) at dilution 1:5000 were incubated
for 1.5 h at room temperature. Finally, the membrane was washed, saturated with BioRad ClarityTM Western ECL Substrate and imaged by a C-Digit blot scanner (Li-Cor
Biosciences, U.S.).

3.3.8 Cell-cycle analysis by flow cytometry
The cells were fixed and stained following the previously described protocol

17.

Briefly,

the cells were seeded in 6-well plates and treated with exosomes (0, 100 and 200
µg/mL) under hypoxia following above-described conditions. Also, untreated cells were
incubated under normoxia. After treatment, the plates were placed on ice and the media
was removed. The cells were washed with ice-cold PBS twice. Two hundred µL of
growth media was added to each well and the cells were scraped. Additional 800 µL of
growth media was added to each well and cells were transferred to 1.5 mL microfuge
tubes. The cells were centrifuged at 1,000 x g for 5 min at 4 °C. After centrifugation, the
supernatant was removed, and the cells were resuspended in 60 μL PBS. Then, 70%
ethanol was added to the cell suspension drop by drop with constant vortexing. The
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cells were left overnight at 4 °C for fixation. After fixation, cells were centrifuged at 300 x
g at room temperature, the supernatant was removed and 1 mL staining mixture
containing propidium iodide and RNase was added. The cells were vortexed and
incubated for 1 h at 37 °C protected from light. Cell cycle analysis was performed using
MACSQuant flow cytometer and data analyzed with MACSQuantify software (Miltenyi
Biotec, Somerville MA).

3.3.9 Statistical analysis
All experiments were performed in at least three independent replicates. All results were
expressed as mean±SD or mean±SEM. Analysis of variance (ANOVA) with Tukey’s test
was done to determine a significant difference (p<0.05) between different treatment
groups using Minitab statistical software (Minitab Inc., Pennsylvania, USA)

3.4 Results and discussion
3.4.1 Identification of bovine milk exosomes isolated from commercially available
milk using particle size
Bovine milk exosomes were isolated from commercially available milk. The particle size
distribution was measured using a dynamic light scattering method. As shown in Fig
3.1, the average particle size of milk exosomes was 152.2 nm ± 4.25 which is consistant
with the literature 18. Polydispersity index (PDI) was 0.289 ± 0.024. In the previously
mentioned article, the size of bovine milk exosomes depends on the maturation stage of
milk 18. Mature milk has a larger particle size distribution when compared with
exosomes isolated from colostrum. In addition, the amount of exosomal miRNA isolated
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from commercially available milk did not significantly differ from the amount of exosomal
miRNA from raw milk suggesting that standard heat treatment does not affect
exosomes 10. The average zeta potential of bovine milk exosomes was -10.9 mV ±
0.834 which would suggest short-term stability. Furthermore, the stability of exosomes
also depends on storage conditions, pH and thaw-freeze cycles 19. Consequently, the
refrigeration temperatures are not recommended for long-term storage and can reduce
exosomal proteins and RNA 20. Bovine milk exosomes isolated from commercially
available milk were positive for exosomal markers ALIX, TSG101 and CD81 (Fig 3.2).
The identification of exosomes has been relying on the presence of ALIX, TSG101 and
CD81 16.

3.4.2 Bovine milk exosomes increased the proliferation of RAW 264.7 cell under
hypoxia
Macrophages are fast acting phagocytic cells of innate immune system

21.

In Fig 3.3,

exosomes treatment significantly increased the proliferation of RAW 264.7 cells when
compared to untreated cells under hypoxia. The cell viability decreased by 27% when
untreated cells were incubated under hypoxia compared to untreated cells incubated
under normal oxygen conditions. Moreover, exosomes treatment at 100 and 200 µg/mL
significantly increased the cells proliferation by 27.9% and 32.6%, respectively. The
results showed that exosomes treatment reversed the anti-proliferative effect of hypoxia
in macrophages and macrophage proliferation when treated with exosomes under
hypoxia is the same as proliferation of macrophages in normoxia. The macrophage cells
exist in two states: tissue-resident and monocyte-derived macrophages 3. Since they
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are the cells of innate immunity, they are the first line of defense when an infection
happens. Often, in the case of inflamed and damaged tissue, the levels of oxygen may
decrease which may cause a decrease in macrophage function and finally apoptosis

22.

Decreased function or apoptosis can lead to a reduced ability of macrophages to fight
an infection. Furthermore, to our knowledge, this is the first report on the effect of
bovine milk exosomes on RAW 264.7 cell proliferation under hypoxia. In a recently
published article, bovine milk exosomes and yak milk exosomes increased the cell
survival of mouse small intestine epithelial cells (IEC-6) under hypoxia conditions 15.
Moreover, in the same article, both yak and bovine milk exosomes were taken up by
IEC-6 in both normoxic and hypoxic conditions.

3.4.3 Bovine milk exosomes reduced production of ROS in RAW 264.7 cell under
hypoxic conditions
Reactive oxygen species are generated under oxidative stress. The oxidative stress
may be defined as an imbalance between free radicals and antioxidants

23.

In our study,

hypoxia caused a significant 4- fold ROS reduction in untreated cells when compared to
the untreated cell under normoxic conditions (Figure 3.4). Furthermore, the exosome
treatment significantly reduced the ROS production when compared to untreated cells in
hypoxic conditions. However, there was no significant difference in ROS production
between the cell treated with 100 µg/mL and 200 µg/mL exosomes. It is still
controversial whether hypoxic conditions increase ROS production. Our findings are not
consistent with current literature 24,25. For instance, when RAW 264.7 cells were
incubated in hypoxic conditions (1% O2) for 20 h, there was a significant increase in
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ROS production when compared to the cell incubated in normoxic conditions

24

and

when RAW 264.7 cells were grown under hypoxia (0.5% O2) for 10 h, there was a
significant increase in ROS production when compared to the cells grown under
normoxia 25. Consequently, differences in exposure time and oxygen concentrations
may have affected the production of ROS.
Cellular hypoxia is more defined as a state of reductive stress where reducing
equivalents such as NADH and FADH2 build up if oxygen is not available 23. Moreover,
the buildup of reducing equivalents makes the electrons more available to reduce the
available oxygen to superoxide. However, even if reducing equivalents are available,
the formation of ROS is not possible when oxygen is not present

26.

It was reported that

the formation of ROS depends on constant cycles of anoxia and reoxygenation

26.

Another study repeated that reoxygenation increased the formation of ROS in RAW
264.7 cell with fast reoxygenation producing more ROS when compared to slow
reoxygenation 24. In our study, we have seen a decrease in ROS when the cells were
exposed to hypoxia and it may be due to exposing the cells to hypoxia for a longer
period of time where no more available oxygen was present to produce ROS. Moreover,
ROS are very short-living molecules with unpaired electrons that are transformed and
eliminated in the variety of cellular processes 27. The reduction in ROS generation in our
study may be explained by possible transformation or elimination of ROS over a
prolonged period under hypoxia when reoxygenation was not present.
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3.4.4 Bovine milk exosomes increased TNF-α in RAW 264.7 under hypoxia
Production of TNF-α was increased in the cells treated with exosomes under hypoxia in
a dose-dependent manner (Fig 3.5). When the cells were treated with 100 µg/mL and
200 µg/mL exosomes, the concentration of TNF-α was 90.8 pg/mL and 172.4 pg/mL
respectively. However, there was no significant difference in the TNF-α concentration
between untreated cell under hypoxia when compared to the untreated cell under
normoxia. Clearly, hypoxia itself was not enough to affect TNF-α production in RAW
264.7 cells which is consistent with the literature where TNF-α was not induced in RAW
264.7 cells in hypoxic conditions even after 48 h 28. TNF-α is a proinflammatory cytokine
that plays an important role in host defense against pathogens

29.

Previously published

study found that the treatment with human TNF-α increased the resistance against
Listeria infection in in vivo mouse model 30. Immunomodulatory effect of bovine milk
exosomes in RAW 264.7 cells under hypoxia that was observed in our study may have
a beneficial effect in fighting an infection in a low oxygen environment. IL-1β, IL-6, and
IL-10 were not affected by hypoxia and exosome treatment.

3.4.5 Bovine milk exosomes did not affect the expression of HIF-1α, p21 and p53
As shown in Fig 3.6, HIF-1α, p21, and p53 were not affected by hypoxia or exosomes
treatment under hypoxia. Although a low oxygen environment is considered to be on the
most important factors of HIF-1α expressions, there is evidence that prolonged hypoxia
may decrease expression of HIF-1α 31. In the previously mentioned study, when the
human lung adenocarcinoma cells (A549) were exposed to 0.5%O2 for 12 h, HIF-1α
expression significantly decreased when compared to the expressions at the exposure
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time of 4 h. The expression of p21 is regulated by p53 32, so it is not surprising that both
proteins were not affected.

3.4.6 Bovine milk exosomes affect the cell cycle of RAW 264.7 cells under
hypoxia
The cell cycle of RAW 264.7 cells under hypoxia and the effect of bovine milk exosomes
on the cell cycle can be seen in Fig 3.6. Our results showed that exposing RAW 264. 7
cells to hypoxia caused cell arrest in the G0/G1 phase of the cell cycle when compared
to the cell under normoxia. The percent number of cells in G0/G1 phase significantly
decreased from 61.3% in untreated cells under hypoxia to 56.7% and 56.9% in the cell
treated with 100 μg/mL and 200 μg/mL exosomes, respectively. There was no
significant difference (p< 0.05) between untreated cells under normoxia and the cells
treated with exosomes under hypoxia suggesting that bovine exosomes treatment is
capable of reversing the effect of hypoxia on cell cycle of RAW 264.7 cell. The number
of cells in pre-apoptotic phase did not significantly differ between different treatments. A
significant reduction of cells in the S phase can be seen in untreated cells exposed to
the hypoxic condition when compared to the cells exposed to normoxic conditions.
Moreover, when the cells were treated with 100 μg/mL and 200 μg/mL exosomes, the
percent of untreated cells under hypoxia in S phase increased from 10.9% to 15.5% and
16.9%, respectively, which was not statistically different from the number of untreated
cells under normoxia in S phase. It is well documented that exposing the cells to a low
oxygen environment affects the cell cycle progression. Not many studies have been
done on the effect of hypoxia on RAW 264.7 cell. One of the previously published
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articles found that exposing RAW 264.7 cells to hypoxia increased the number of
apoptotic cells in 24 h 33. While our study did not find any difference in the number of
apoptotic cells, the arrest in G0/G1 and reduction of cells in S phase was consistent
with the current literature 34. To our knowledge, this is the first study that investigates
the effect of bovine milk exosomes on the cell cycle progression in RAW 264.7 cells
under hypoxia. Clearly, bovine milk exosomes were able to reverse the effect of hypoxia
on the cell cycle of RAW 264.7 cells.

3.5 Conclusion
Our study found that bovine milk exosomes are present in commercially available
bovine milk suggesting that the pasteurization process does not destroy them. Their
bioactivity was investigated in RAW 264.7 cells subjected to hypoxia, and we found that
bovine milk exosomes can reverse adverse effects caused in a case of low oxygen
supply which can be seen in damaged or inflamed tissue. Further investigation on a
deeper understanding by which mechanism bovine milk exosomes reverse the effect of
hypoxia in immune cells is needed.
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Figure 3.1. Particle size (A) and zeta potential (B) of bovine milk exosomes.
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Figure 3.2. Exosomal markers ALIX, TSG101 and CD81.
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Figure 3.3. Proliferation of RAW 264.7 cell treated with bovine milk exosomes under
hypoxia. Results are presented as mean ± SD. Means that do not share a letter are
significantly different (p<0.05).
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Figure 3.4. Relative production of reactive oxygen production (ROS) in RAW 264.7 cell
treated with bovine milk exosomes under hypoxia. Results are presented as mean ±
SD. Means that do not share a letter are significantly different (p<0.05).
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Figure 3.5. TNF-α production in RAW 264.7 cells treated with bovine milk exosomes.
Results are presented as mean ± SD. Means that do not share a letter are significantly
different (p<0.05).
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Figure 3.6. Effect of milk exosomes on RAW 264.7 expression of hypoxia protein HIF1α and proliferation proteins p53 and p21. Results are presented as mean ± SE. Means
that do not share a letter are significantly different (p<0.05).
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Figure 3.7. The effect of hypoxia and bovine milk treatment on the cell cycle of RAW
264.7 cells. Results are presented as mean ± SD. Means that do not share a letter are
significantly different (p<0.05).
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CHAPTER 4: CONCLUSION AND FUTURE WORK

It has been well-documented that the consumption of bovine milk has multiple benefits
on human health. Recently, the discovery of exosomes and their presence in bovine
milk contributed to a better understanding of how milk affects human health. Our study
found that exosomes are present in commercially available milk suggesting that
pasteurization temperatures do not destroy their integrity. The presence of exosomes
after pasteurization process suggests that consuming heat-treated may not affect their
biological activity but also this may be important for the potential application in the food
industry. Also, our results supported the previously published findings that bovine milk
exosomes are stable and can resist in vitro digestion suggesting that bovine milk
exosomes may reach small intestines and therefore be absorbed in an intact form.
Bovine milk exosomes increased the proliferation and protect RAW 264.7 cells from
cisplatin-induced apoptosis in normoxia. Moreover, bovine milk exosome treatment
significantly increased cells proliferation and had an immunomodulatory effect under
hypoxia. Our results suggest that bovine milk exosomes could have a beneficial effect
on human health so further research is needed to understand their biological activity.
Bovine milk exosomes have not been extensively studied so there is still a lot unknown
about the topic. Clearly, for any further research, isolation of bovine milk exosomes
needs to be improved. Our study demonstrated that differential centrifugation along with
filtration was not enough to remove all residual milk proteins. Application of pH or
enzymes could be used to remove residual proteins before subjecting it to differential
ultracentrifugation.
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As a bioactive milk component, the stability of milk exosomes over time, and how the
storage time affects their bioactivity and uptake should be investigated. To our
knowledge, no study has been published on the effect of storage condition and time on
the stability of bovine milk exosomes. Also, we demonstrated that bovine milk
exosomes resisted in vitro digestion so the next step would be to investigate their
uptake and internalization in vivo using animal models.
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